PeerCurrent.com|Stay current with the people and research shaping what comes next.

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Researcher

Fei Xiao

Guangdong Academy of Medical Sciences

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 12, 2026 · JOURNAL ARTICLE

Cerium molybdate-doped polyaniline nanoplatform for GSH-depletion-enhanced chemodynamic/NIR-II photothermal synergistic therapy via ferroptosis and immune activation

Bioactive Materials

This is a preclinical mechanistic study of a novel nanoparticle in an experimental system; it demonstrates proof-of-concept but lacks clinical translation, human data, or controlled comparison to standard therapy.

Hypothesis-GeneratingBolan Yu Lie Li Ping Zhu

Study details

DesignPreclinical mechanistic study

InterventionCerium molybdate-doped polyaniline nanopart…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support